Aurora Labs Limited (ASX:A3D) has filed an Appendix 3B disclosing a proposed issue of three classes of securities totalling approximately 26.9 million securities, including unlisted options, performance rights, and ordinary shares, with a proposed issue date of 4 December 2026.

Key Points

  • 18,000,000 unlisted options expiring three years from the date of issue at an exercise price of $0.12 are proposed to be issued as director incentive options.
  • 7,250,000 Performance Rights (November 2026) are proposed to be issued as a performance-linked incentive component in director remuneration packages.
  • 1,689,496 fully paid ordinary shares are proposed to be issued in satisfaction of outstanding directors' fees, with an estimated AUD equivalent of $84,329.67.
  • The proposed issue date for all three classes of securities is 4 December 2026.

Ordinary Share Issue in Satisfaction of Directors' Fees

According to the filing, Aurora Labs has proposed to issue 1,689,496 fully paid ordinary shares (ASX:A3D) with an estimated AUD equivalent consideration of $84,329.67. The filing states that these shares are being issued in satisfaction of outstanding directors' fees. The securities are described as an existing class and will rank equally in all respects from their issue date with existing issued securities in that class. No cash consideration is involved in this component of the proposed issue.

Director Incentive Options Details

The filing discloses that 18,000,000 unlisted options are proposed to be issued, each with an exercise price of AUD $0.12 and expiring three years from the date of issue. The estimated AUD equivalent of the consideration being provided is $216,000. The filing states that the main purpose of the issue of these Director Incentive Options is to provide a retention incentive component in the remuneration package for the directors. Each option, if exercised, will result in the issue of one fully paid ordinary share in Aurora Labs (ASX:A3D). These options constitute a new class of securities.

Performance Rights November 2026 Issuance

Aurora Labs has also proposed to issue 7,250,000 Performance Rights designated as "Performance Rights November 2026," representing a new class of performance options and rights. The filing states the purpose of this issue is to provide a performance-linked incentive component in the remuneration package for the directors, with an estimated AUD equivalent consideration of $92,075. Each performance right, if exercised, will result in the issue of one fully paid ordinary share (ASX:A3D). No cash consideration is involved, and all securities in this class will rank equally from their issue date.